1. Home
  2. MRTN vs DBVT Comparison

MRTN vs DBVT Comparison

Compare MRTN & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marten Transport Ltd.

MRTN

Marten Transport Ltd.

HOLD

Current Price

$11.62

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.51

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRTN
DBVT
Founded
1946
2002
Country
United States
France
Employees
N/A
90
Industry
Trucking Freight/Courier Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
MRTN
DBVT
Price
$11.62
$19.51
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$31.75
AVG Volume (30 Days)
539.9K
218.4K
Earning Date
04-15-2026
04-29-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$1,131,455,000.00
$4,151,000.00
Revenue This Year
N/A
$65.50
Revenue Next Year
$10.12
$47.02
P/E Ratio
$55.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.35
$3.91
52 Week High
$14.19
$26.19

Technical Indicators

Market Signals
Indicator
MRTN
DBVT
Relative Strength Index (RSI) 32.41 41.23
Support Level $11.43 $8.55
Resistance Level $12.19 $24.47
Average True Range (ATR) 0.44 1.50
MACD -0.19 -0.35
Stochastic Oscillator 6.78 16.36

Price Performance

Historical Comparison
MRTN
DBVT

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: